HomeCTMX • NASDAQ
add
CytomX Therapeutics Inc
Previous close
$2.21
Day range
$2.18 - $2.40
Year range
$0.40 - $3.10
Market cap
363.93M USD
Avg Volume
4.45M
P/E ratio
4.81
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 50.92M | 22.80% |
Operating expense | 28.30M | -5.07% |
Net income | 23.52M | 70.58% |
Net profit margin | 46.20 | 38.91% |
Earnings per share | 0.27 | 58.82% |
EBITDA | 23.01M | 89.76% |
Effective tax rate | 0.26% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 79.89M | -46.84% |
Total assets | 98.50M | -46.67% |
Total liabilities | 73.45M | -66.05% |
Total equity | 25.05M | — |
Shares outstanding | 80.62M | — |
Price to book | 7.13 | — |
Return on assets | 51.64% | — |
Return on capital | 268.49% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 23.52M | 70.58% |
Cash from operations | -21.04M | 19.21% |
Cash from investing | 30.60M | -31.83% |
Cash from financing | — | — |
Net change in cash | 9.55M | -49.76% |
Free cash flow | -19.37M | -84.39% |
About
Founded
2008
Headquarters
Website
Employees
120
